Charalampos M. Charalampous

Dr. Charalampos M. Charalampous

Department of Surgery, The Ohio State University, Columbus, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
APAMALIA PAPANIKOLOPOULOU
AMALIA PAPANIKOLOPOULOU
VRVasiliki Rapti
Vasiliki Rapti
PAPolyxeni Alexiou
Polyxeni Alexiou
Charalampos M. CharalampousCharalampos M. Charalampous
Charalampos M. Charalampous
MLMaria Effrosyni Livanou
Maria Effrosyni Livanou
GPGaryphallia Poulakou
Garyphallia Poulakou
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been studied as predictors for severe COVID-19 outcomes. The aim of the present study is to identify prognostic cut-off values of NLR and PLR for intubation and death in hospitalized COVID-19 patients, with or without immunosuppression. From June 2021 to December 2022, we retrospectively analyzed 393 consecutively admitted COVID-19 patients, who were divided in two cohorts according to immunosuppression status (hematological malignancy and/or autoimmune condition vs. non-immunocompromised), using a propensity score-matching in 1:2 ratio. Higher NLR and PLR values were observed on days 1 and 4 for severe COVID-19, irrespective of immunosuppression status. NLR on day 1 >5.06 and day 4 >6.40 (p < 0.001), as well as PLR on day 1 >262.2 and day 4 >217.3 (p = 0.003), were associated with a greater probability for intubation. Similarly, a higher probability for death was found in the subset of patients with NLR on day 1 >4.82 (p < 0.001) and day 4 >6.41 (p < 0.001) and PLR on day 1 >229 (p = 0.009) and day 4 >205.4 (p = 0.003). Both PLR and NLR exhibited consistently higher negative predictive values (NPVs) (>93%) compared to positive predictive values (PPVs) for intubation and death. NLR and PLR displayed strong prognostic potential in hospitalized COVID-19 patients regarding intubation and death, irrespective of immunosuppression status, thus the surveillance of these biomarkers may help clinicians identify high-risk COVID-19 patients at an early stage.

4 August 2023 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
Charalampos M. CharalampousCharalampos M. Charalampous
Charalampos M. Charalampous
EKE Kofopoulos-Lymperis
E Kofopoulos-Lymperis
APA Pikouli
A Pikouli
PLP Lykoudis
P Lykoudis
NPN Pararas
N Pararas
DDD Dellaportas
D Dellaportas
Gastric conduit reconstruction is the standard choice after esophagectomy. Conduit’s vascular supply is of primary importance mainly based on right gastroepiploic vessels. A 57-year-old male with absent right gastroepiploic artery, due to a duodenal bleeding ulcer treated with gastroduodenal artery ligation 10 years ago, was treated for gastroesophageal cancer and required esophagectomy. Surgical merits of this troublesome scenario are highlighted. Previous surgical history is highly important for patients requiring complex surgery as esophagectomy. The use of the stomach as conduit after esophagectomy is always the primary option; however vascular supply of it should not be compromised. Variations are rare and careful planning may overcome obstacles as in this case.

15 April 2026 in HPB
Verified
Journal Article
Open access
QAQaidar Alizai
Qaidar Alizai
OCOdysseas P. Chatzipanagiotou
Odysseas P. Chatzipanagiotou
Charalampos M. CharalampousCharalampos M. Charalampous
Charalampos M. Charalampous
AMAreesh Mevawalla
Areesh Mevawalla
MAMeher Angez
Meher Angez
Tim PawlikTim Pawlik
Tim Pawlik
Clostridium difficile infection (CDI) is a common healthcare-associated infection. We assessed the incidence, timing, risk factors, and outcomes of CDI following liver and pancreatic resection. Adults undergoing elective hepatic or pancreatic resection were identified in ACS-NSQIP (2015-2021). The primary exposure was 30-day postoperative CDI. Outcomes included 30-day mortality, non-home discharge, unplanned readmission, and length of stay (LOS). Multivariable regression analyses were conducted. Among 76,083 patients (liver: 30,145 [39.6%], pancreas: 45,938 [60.4%]), 860 (1.1%) developed CDI, including 236 hepatic and 624 pancreatic cases. Overall, 44.8% occurred within the first postoperative week. Patients with CDI were more often aged ≥75 years, ASA III-V, on preoperative dialysis, and had CHF (all p<0.05). Following hepatic resection, CDI was associated with increased mortality (aOR 3.64, 95%CI 1.60-8.28), readmission (aOR 2.78, 95%CI 2.00-3.85), and longer LOS (+3.25 days, 95%CI 2.82-3.68). Following pancreatic resection, CDI was associated with readmission (aOR 2.29, 95%CI 1.89-2.78) and prolonged LOS (+3.00 days, 95%CI 2.76-3.24). CDI occurred in 1.1% of HP surgery patients, nearly half within the first postoperative week, and was associated with worse outcomes. Early identification of high-risk patients may improve prevention and management.

20 April 2026 in JCO Oncology Practice
Verified
Journal Article
Closed access
SESebastian O. Ekenze
Sebastian O. Ekenze
SKShreyas Krishna
Shreyas Krishna
AEAbdulaziz Elemosho
Abdulaziz Elemosho
Charalampos M. CharalampousCharalampos M. Charalampous
Charalampos M. Charalampous
Tim PawlikTim Pawlik
Tim Pawlik
PURPOSE: Subjective cognitive decline (SCD) may signal early neurocognitive vulnerability. The prevalence of SCD among the general population and cancer survivors has not been well-defined. We sought to quantify SCD burden and identify key determinants of SCD among cancer survivors. MATERIALS AND METHODS: Cancer survivors from the 2022 to 2024 Behavioral Risk Factor Surveillance System (BRFSS) were identified and matched with noncancer controls. SCD was defined using the BRFSS Cognitive Decline module as self-reported worsening memory or confusion over the past 12 months. Survey-weighted logistic regression models were used to estimate SCD prevalence and identify sociodemographic and clinical predictors adjusting for sociodemographic, behavioral, and health-related factors. RESULTS: Among 50,970 participants, 33.3% (n = 16,990) had cancer, 68% (n = 36,660) was 65 years and older, 58.7% (n = 29,919) was female, and 77.8% (n = 39,655) identified as non-Hispanic White. SCD prevalence was higher among cancer survivors than noncancer adults (8.9% [95% CI, 8.1 to 9.7] v 6.6% [95% CI, 6.1 to 7.1]; P < .001) with the greatest burden among survivors age 45-54 years (15.0% [95% CI, 10.5 to 19.6]; P < .01). Factors strongly associated with SCD in cancer survivors were depression (adjusted odds ratio [aOR], 3.13 [95% CI, 2.45 to 4.01]) and poor general health (aOR, 2.03 [95% CI, 1.58 to 2.61]; all P < .001), as well as past stroke (aOR, 1.89 [95% CI, 1.27 to 2.80]; P = .022) and past smoking habit (aOR, 1.44 [95% CI, 1.13 to 1.84]; P = .041). The association of depression with SCD was highest among non-Hispanic Black survivors (aOR, 6.70 [95% CI, 2.97 to 15.11]). CONCLUSION: Cancer survivors, especially in midlife, face a higher risk of SCD. Depression and poor general health were the strongest determinants of SCD, with past stroke event and past smoking habits also associated with SCD development. Strengthening survivorship care through equitable screening for cognitive concerns and psychological distress with targeted referrals as clinically indicated may support early identification of survivors reporting cognitive concerns and inform care for cancer survivors.

AMAreesh Mevawalla
Areesh Mevawalla
Aayan E KibriaAayan E Kibria
Aayan E Kibria
MAMeher Angez
Meher Angez
Charalampos M. CharalampousCharalampos M. Charalampous
Charalampos M. Charalampous
AEAbdulaziz Elemosho
Abdulaziz Elemosho
Tim PawlikTim Pawlik
Tim Pawlik
Microplastics are pervasive contaminants in marine and coastal ecosystems. Although experimental and human biomonitoring studies suggest biologic plausibility for chronic health effects, population-level evidence linking environmental microplastic exposure to cancer incidence remains limited. We conducted a county-level ecological study of 255 U.S. coastal counties linking NOAA/NCEI marine microplastic exposure data with NCI/CDC State Cancer Profiles cancer incidence estimates. Counties were categorized by mean marine microplastic concentration as low, medium, or high exposure. Outcomes included incidence rates per 100,000 population for colorectal, lung, pancreatic, liver and intrahepatic bile duct, esophageal, kidney, thyroid, breast, prostate, and cervical cancers. Poisson regression was used to estimate incidence rate ratios (IRRs) comparing medium- and high-exposure counties with low-exposure counties, adjusting for county-level demographic, socioeconomic, healthcare access, and geographic covariates. Among 255 coastal counties, 53 (20.8%) had low exposure, 36 (14.1%) medium exposure, and 166 (65.1%) high exposure. High-exposure counties were more frequently located along the Atlantic and Gulf coasts and had a lower median household income, higher poverty, and higher uninsured rates than low-exposure counties. In adjusted models, higher microplastic exposure was not associated with a broad or consistent increase in cancer incidence across sites. For pancreatic cancer, the IRR comparing high- with low-exposure counties was 1.18 (95% CI 0.99–1.26), with no statistically significant overall association across exposure categories (p = 0.09). Marine microplastic exposure was geographically and socioeconomically patterned across U.S. coastal counties, but current county-level exposure metrics did not reveal a consistent population-level cancer signal. Improved exposure assessment and longitudinal individual-level studies are needed.

12 November 2026 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
MAMeher Angez
Meher Angez
Charalampos M. CharalampousCharalampos M. Charalampous
Charalampos M. Charalampous
RERida Ejaz
Rida Ejaz
KHKamran Hussain
Kamran Hussain
AAAbdul Ali
Abdul Ali
Tim PawlikTim Pawlik
Tim Pawlik